Personalised Pregnancy Testing in Bengaluru: A Smarter Guide to Prenatal Care

Could the right pregnancy blood tests help identify important health concerns before symptoms appear? Learn which antenatal tests matter at each stage, what new AI research really shows, and how to plan doctor-guided screening in Bengaluru.

Clinical Note: Quick answer: Personalised prenatal testing means choosing suitable investigations according to gestational age, maternal health, previous pregnancies and an obstetrician’s advice. It does not mean every pregnant woman needs more tests—or that AI can diagnose pregnancy complications.

Every pregnancy is different. Two women at the same week of pregnancy can have very different care needs. One may have had gestational diabetes before, another may have thyroid disease, and a third may have no obvious risk factors. A thoughtful antenatal plan combines regular obstetric visits, the right laboratory investigations and ultrasound assessments rather than a one-size-fits-all test package.

At QXL Diagnostics in Bengaluru, the aim of prenatal laboratory care is to make appropriate investigations easier to understand and access. QXL provides laboratory testing and sample collection; your obstetrician remains responsible for selecting investigations and deciding how the results affect treatment.

What did the new 2026 AI pregnancy study discover?#

A multicentre study published in the Journal of Medical Internet Research on 26 August 2026 analysed 771,101 pregnancies from Sweden (727,354), Chile (5,934) and Singapore (37,813). Researchers built and internally evaluated separate machine-learning models using information available during the first 14 weeks of pregnancy. The models estimated the chance of a combined set of adverse outcomes for mothers and babies [1].

The best-performing reported model achieved an AUROC—one measure of how well predictions distinguish higher- from lower-risk pregnancies—of 0.65 in Sweden and Chile, and 0.60 in Singapore. The clinical approaches used for comparison scored approximately 0.53, 0.52 and 0.56, respectively. These differences are encouraging for research, but the model performance was moderate rather than sufficiently precise to promise reliable predictions for an individual family [1].

The study also suggested that social circumstances and demographic information could add useful context. Model performance and calibration differed between countries, reinforcing the need for population-specific testing. Importantly, the models were retrospectively developed and internally validated; they have not been demonstrated to improve health outcomes through routine clinical deployment in India [1].

A separate 2026 systematic review of 90 studies found that many machine-learning models for preterm birth, small-for-gestational-age babies or stillbirth were at high risk of bias and did not consistently outperform traditional statistical approaches [2].

Clinical Note: What this means today: AI may become an additional tool for obstetric teams, but it is not a substitute for clinical examinations, regular antenatal care, ultrasound, standard screening or timely referral. QXL does not claim to offer the AI risk model examined in this study.

What is personalised pregnancy testing?#

Personalised pregnancy testing is a doctor-guided plan for choosing laboratory tests based on your medical history, current pregnancy and stage of gestation. It usually includes evidence-based routine antenatal tests, with additional testing only when clinically indicated.

• Your current gestational age and estimated due date.
• Previous gestational diabetes, pre-eclampsia, preterm delivery or other pregnancy complications.
• Anaemia, haemoglobin disorders, diabetes, thyroid or kidney disease.
• Single or multiple pregnancy and relevant ultrasound results.
• Family history of inherited conditions and previous prenatal screening results.
• Current symptoms, medicines and other relevant medical findings. Personalised care should also respect informed choice. A patient can discuss the benefits, limitations and costs of prenatal screening with her clinician and may accept or decline genetic screening or diagnostic testing after appropriate counselling [3].

Pregnancy tests by trimester: an easy timeline#

Early pregnancy: booking visit and first trimester#

The initial antenatal visit establishes a maternal health baseline. Depending on the clinical setting and history, frequently recommended investigations include:

• Complete blood count (CBC): assesses haemoglobin, red-cell indices and platelets, including anaemia screening.
• ABO and Rh(D) group with an antibody screen: helps identify red-cell alloimmunisation risk.
• HIV, hepatitis B surface antigen and syphilis screening: important maternal infection screening, with counselling and applicable consent [4].
• Urinalysis and/or urine culture: selected according to antenatal practice for urinary infection assessment.
• Blood glucose assessment: early screening may be advised, especially with previous gestational diabetes or diabetes risk; a later assessment may still be required.
• Thyroid-stimulating hormone, haemoglobinopathy screening, ferritin and other tests when clinically indicated. First-trimester ultrasound is important for dating, viability and assessment of the pregnancy, with further imaging determined by your obstetrician.

11 weeks to 13 weeks + 6 days: double marker and combined screening#

The double marker test measures maternal serum PAPP-A (pregnancy-associated plasma protein A) and free beta-hCG. When combined with a qualified nuchal translucency (NT) ultrasound and maternal information, it helps estimate the chance of selected chromosomal conditions, including trisomy 21, trisomy 18 and trisomy 13. This is a SCREENING test, not a diagnosis [3].

Correct gestational age, maternal age, weight, diabetes status, plurality and relevant scan findings help support interpretation. A higher-risk result deserves discussion with the obstetrician; a lower-risk result does not exclude every genetic or structural condition.

QXL test information: Double Marker Test in Bengaluru (confirm the exact laboratory protocol and applicable screening window before collection).

From about 10 weeks: NIPT / cell-free DNA screening#

Non-invasive prenatal testing (NIPT), also called cell-free DNA screening, analyses DNA fragments in maternal blood, mostly derived from the placenta. It is the most sensitive and specific screening approach for common fetal trisomies when appropriately used, but false-positive, false-negative and inconclusive results can occur [3, 5].

A high-risk NIPT result requires genetic counselling and an offer of diagnostic confirmation through chorionic villus sampling (CVS) or amniocentesis as appropriate. NIPT does not replace the 18–22-week anatomical ultrasound. An obstetrician should help select one suitable aneuploidy screening pathway rather than ordering several overlapping screens automatically [3, 5].

Clinical Note: Availability note: This article discusses NIPT for patient education. Do not advertise NIPT as a QXL service unless the laboratory or its authorised referral pathway has independently confirmed current availability, scope and reporting process.

Second trimester: approximately 14 to 27 weeks#

If first-trimester chromosomal screening was not completed, second-trimester serum screening may be offered according to gestational age and the chosen clinical pathway. The triple marker test assesses maternal serum AFP, total hCG and unconjugated oestriol (uE3). The quadruple marker test adds inhibin A. These tests estimate risks of selected chromosomal conditions and, through AFP, can help screen for open neural tube defects. They do not provide a definitive diagnosis.

QXL’s published triple and quadruple marker pages describe sample collection between 15 weeks 0 days and 20 weeks 6 days; precise suitability must be verified with the current validated method and treating clinician. A detailed fetal anatomy ultrasound is normally offered at 18–22 weeks regardless of aneuploidy-screening choice [3, 5].

ExploreTriple Marker ScreeningandQuadruple Marker Screeningat QXL.

24 to 28 weeks: gestational diabetes screening#

Gestational diabetes often causes no obvious symptoms. Testing helps identify women who may benefit from nutritional advice, glucose monitoring and clinician-directed treatment. Indian national maternal-health guidance describes a 75-g oral glucose protocol at the first antenatal contact and repeat testing at 24–28 weeks if the earlier result is negative, with specified conditions [6].

Other internationally used diagnostic protocols may require fasting and different sampling schedules. Do not assume all oral glucose tolerance tests are interchangeable: follow the exact protocol prescribed by the obstetrician and confirmed by the laboratory.

Third trimester: approximately 28 weeks to delivery#

Repeat laboratory investigations depend on previous findings, symptoms and clinical assessment. They may include CBC, clinically indicated glucose checks, repeat antibody or infection screening, and urine protein, platelet, kidney or liver investigations when a hypertensive disorder or another complication is suspected. Blood pressure checks, fetal growth assessment and antenatal visits remain essential. No blood test replaces the overall clinical picture.

Can blood tests predict pre-eclampsia?#

Pre-eclampsia involves pregnancy-related hypertension and can affect the kidneys, liver, brain, placenta and other organs. A history of pre-eclampsia, chronic hypertension, pre-existing diabetes, kidney disease or multiple pregnancy may increase risk. Some specialist pathways use blood pressure, uterine artery Doppler assessment and selected biochemical markers to estimate risk. No isolated serum biomarker, including PAPP-A, establishes pre-eclampsia or reliably predicts an individual outcome by itself.

For some women at increased risk, the obstetrician may recommend low-dose aspirin after evaluating contraindications and relevant guidance. Never begin aspirin or any medication solely on the basis of an online article or an isolated test result [7].

How should I read a prenatal screening report?#

Some chromosomal screening reports express probability as ratios. An estimated risk of 1 in 100 is higher than 1 in 1,000, but even a “screen-positive” report is not proof that the fetus has the condition. Likewise, “screen-negative” reduces estimated risk only for the conditions and testing method assessed.

Your clinician may review gestational dating, relevant ultrasound findings, screening thresholds, and the possibility of further genetic counselling or diagnostic testing. Avoid interpreting a marker concentration as a stand-alone diagnosis or comparing your result with another patient’s report.

Who may need more individualised monitoring?#

• Women with previous gestational diabetes or diabetes before pregnancy.
• Women with previous pre-eclampsia, high blood pressure or kidney disease.
• Those with previous preterm birth or a history of repeated pregnancy complications.
• Women with thyroid disease or haemoglobin disorders.
• Those carrying twins or higher-order multiple pregnancies.
• Women with a family history of inherited disorders or concerning ultrasound findings.
• Those with symptoms, new abnormal results or another clinical indication for closer follow-up. An increased risk factor does not mean a complication will occur. Risk assessment should prompt a constructive discussion about suitable care, not unnecessary anxiety or indiscriminate “high-risk” test packages.

QXL Diagnostics: prenatal blood testing and home collection in Bengaluru#

QXL Diagnostics is a doctor-led diagnostic laboratory in Bengaluru. Its website lists NABL accreditation certificate MC-6849 and prenatal serum screening pages for the double, triple and quadruple marker tests. The published laboratory location is 3rd Floor, SLN Complex, Mysore Road, Kengeri, Bengaluru 560060; the website also lists a Yelahanka hub [8]. Accreditation claims for a specific test must always match the current NABL scope rather than being assumed from the laboratory’s overall accreditation.

For suitable tests, QXL advertises home sample collection across Bengaluru. Prenatal serum screening may need gestational age, maternal details and ultrasound information; timed glucose tolerance testing can need specific collection logistics. Confirm test availability, preparation, turnaround time, accredited scope and sample suitability while booking.

Book a test online|Explore Bengaluru home collection|WhatsApp QXL Diagnostics| Call +91 9964 639 639.

Five questions to ask before booking any pregnancy test#

• What is my exact gestational age, based on the dating scan?
• Is the test routine at this stage or advised because of a particular clinical concern?
• Am I choosing screening or diagnostic testing, and what can it NOT tell me?
• What follow-up will be recommended for a high-risk, low-risk or inconclusive result?
• What prescription, ultrasound information, preparation or special collection time is required?

When should I seek urgent medical care?#

Do not wait for a routine blood test or home collection appointment if you experience heavy vaginal bleeding, severe abdominal pain, severe or persistent headache, vision changes, fainting, significant breathing difficulty, fits/seizures, or reduced fetal movements once established. Seek urgent obstetric evaluation. New severe symptoms always take priority over planned screening.

Frequently asked questions about personalised pregnancy testing#

What is personalised pregnancy testing?#

It is a clinician-guided choice of antenatal tests based on pregnancy stage, medical history, risk factors and previous results. It does not mean every patient needs a large test panel.

Which blood tests are commonly done in early pregnancy?#

Common early investigations include CBC, blood group/Rh typing, antibody screening and selected infection screening. Glucose, thyroid, haemoglobinopathy and other investigations depend on the care plan.

Can AI predict whether my pregnancy is high risk?#

Research models may help identify higher-risk groups, but current prediction is imperfect. AI cannot guarantee outcomes and should not replace an obstetrician.

Does QXL offer the AI pregnancy prediction model described in the research?#

This article does not represent that experimental model as a QXL service. QXL offers laboratory tests that clinicians may use as part of established prenatal care.

When is the double marker test performed?#

Usually during the 11-week to 13-week-and-6-day combined first-trimester screening window, with scan dating and other required information.

Is the double marker test a diagnosis for Down syndrome?#

No. It estimates a chance, usually combined with ultrasound and patient data. A higher-risk result may require specialist counselling and further investigations.

How is NIPT different from the double marker test?#

NIPT screens placental cell-free DNA for selected chromosomal conditions and is generally more sensitive for common trisomies. The double marker test measures maternal serum proteins and commonly incorporates NT ultrasound.

Is NIPT a confirmatory test?#

No. NIPT is a screening test. A high-risk result requires discussion of diagnostic confirmation with CVS or amniocentesis as appropriate.

What if I missed the first-trimester screening window?#

Discuss second-trimester screening, cell-free DNA screening and ultrasound options with your obstetrician. The best choice depends on the pregnancy stage and earlier results.

When is the triple marker or quadruple marker test done?#

QXL’s published testing pages describe a 15-week to 20-week-and-6-day window. Confirm eligibility using your scan dating and the laboratory’s current protocol.

Are pregnancy blood tests safe for the baby?#

Routine maternal blood collection generally does not directly involve the fetus. Diagnostic procedures such as CVS and amniocentesis have different benefits and risks and require specialist counselling.

Do I have to fast for the double marker test?#

Fasting is not usually required for double marker screening. Some glucose tests do require special preparation, depending on the exact protocol.

When should I be screened for gestational diabetes?#

Your clinician may arrange early assessment and a further test around 24–28 weeks. Indian and international protocols differ in sampling requirements, so follow the prescribed method.

Can blood tests alone diagnose pre-eclampsia?#

No. Diagnosis and management require clinical evaluation, including blood pressure and potentially other investigations. A single biochemical marker cannot establish the diagnosis.

Does a “high-risk” prenatal screening result mean my baby has a disorder?#

No. Screening reports estimate probability; further counselling and diagnostic testing may be offered to establish whether a specified disorder is present.

Can prenatal tests tell me my baby’s sex in India?#

Prenatal sex determination and disclosure for non-permitted purposes are prohibited under India’s PC & PNDT legislation. Testing must be for legally permitted medical indications.

Can QXL collect pregnancy blood tests at home in Bengaluru?#

QXL advertises Bengaluru home collection for suitable tests. Contact the laboratory to confirm prenatal-test eligibility, instructions and appointment availability.

How can I book a pregnancy blood test at QXL Diagnostics?#

Contact QXL on +91 9964 639 639 or use qxldiagnostics.com/book. Keep your prescription, gestational age and relevant ultrasound records available.

Ready to plan your next pregnancy blood test?#

Healthy pregnancy care is not about ordering the maximum number of investigations. It is about choosing appropriate tests, understanding the results and getting the right clinical follow-up at the right time. Share your obstetrician’s prescription with QXL Diagnostics and confirm the relevant preparation and sample requirements before booking.

Clinical Note: QXL DIAGNOSTICS | Doctor-led laboratory services | Kengeri and Yelahanka, Bengaluru | +91 9964 639 639 | www.qxldiagnostics.com

Medical disclaimer: This article is educational and does not replace consultation, ultrasound assessment, prenatal genetic counselling or obstetric management. Clinical suitability and test availability must be confirmed individually. Reviewed-by credentials and final publication date must be approved and updated before publishing.

Medical references#

1. [1] Li S, et al. Machine Learning–Based First-Trimester Antenatal Risk Prediction for Adverse Maternal and Neonatal Outcomes. J Med Internet Res. 2026;28:e88450. DOI: 10.2196/88450.
2. [2] Zhang J, et al. Machine learning to predict adverse perinatal outcomes: a systematic review and meta-analysis. eClinicalMedicine. 2026;98:104138. DOI: 10.1016/j.eclinm.2026.104138.
3. [3] ACOG. Prenatal Genetic Screening Tests (patient FAQ).
4. [4] WHO. Testing in pregnancy for HIV, syphilis and hepatitis B.
5. [5] ACOG. Screening for Fetal Chromosomal Abnormalities, practice advisory, January 2026.
6. [6] Government of India, Ministry of Health and Family Welfare. National Guidelines for Diagnosis & Management of Gestational Diabetes Mellitus.
7. [7] ACOG. Low-Dose Aspirin Use for the Prevention of Preeclampsia and Related Morbidity and Mortality.
8. [8] QXL Diagnostics: laboratory information and current services.